The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 11, Issue 503, Pages eaaw4993
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-08-01
DOI
10.1126/scitranslmed.aaw4993
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer
- (2018) Laura Graham et al. INVESTIGATIONAL NEW DRUGS
- Translation from unconventional 5′ start sites drives tumour initiation
- (2017) Ataman Sendoel et al. NATURE
- A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer
- (2017) Xiao X. Wei et al. ONCOLOGIST
- Androgen Deficiency Exacerbates High-Fat Diet-Induced Metabolic Alterations in Male Mice
- (2016) Vanessa Dubois et al. ENDOCRINOLOGY
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Genome-wide assessment of differential translations with ribosome profiling data
- (2016) Zhengtao Xiao et al. Nature Communications
- Increased 4E-BP1 Expression Protects against Diet-Induced Obesity and Insulin Resistance in Male Mice
- (2016) Shih-Yin Tsai et al. Cell Reports
- KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2
- (2015) L Jia et al. ONCOGENE
- Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors
- (2015) Andrew C. Hsieh et al. Science Signaling
- Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors
- (2015) Andrew C. Hsieh et al. Science Signaling
- eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
- (2014) Lise Boussemart et al. NATURE
- Haematopoietic stem cells require a highly regulated protein synthesis rate
- (2014) Robert A. J. Signer et al. NATURE
- DENR–MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth
- (2014) Sibylle Schleich et al. NATURE
- CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells
- (2013) Tian Jun Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
- (2013) Yu Chen et al. NATURE MEDICINE
- Translational Homeostasis via the mRNA Cap-Binding Protein, eIF4E
- (2012) Akiko Yanagiya et al. MOLECULAR CELL
- A unifying model for mTORC1-mediated regulation of mRNA translation
- (2012) Carson C. Thoreen et al. NATURE
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- FIMO: scanning for occurrences of a given motif
- (2011) Charles E. Grant et al. BIOINFORMATICS
- Blocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication
- (2011) R. Cencic et al. JOURNAL OF VIROLOGY
- Global quantification of mammalian gene expression control
- (2011) Björn Schwanhäusser et al. NATURE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
- (2010) Andrew C. Hsieh et al. CANCER CELL
- A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
- (2010) A. J. Armstrong et al. CLINICAL CANCER RESEARCH
- Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
- (2010) A. C. Hsieh et al. CLINICAL CANCER RESEARCH
- Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F
- (2010) R. Cencic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
- (2010) L. Furic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
- (2010) R. J. O. Dowling et al. SCIENCE
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling
- (2009) N. T. Ingolia et al. SCIENCE
- Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells
- (2008) Andrea Bianchini et al. CARCINOGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation